Last Updated: 02/12/2024
Using immunological principles to inform malaria vaccine design
Objectives
To generate a vaccine that induces sustained levels of high-quality antibodies targeting multiple targets on the parasite and so can provide sustained long-term protection.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria kills ~420,000 people each year worldwide. While a vaccine does exist, efficacy is poor and protection wanes rapidly. We have made breakthroughs in understanding the immune response to malaria that allow us to design a new generation of malaria vaccines. Based on this we aim to generate a vaccine that induces sustained levels of high-quality antibodies targeting multiple targets on the parasite and so can provide sustained long-term protection.
External reference
Thematic Categories
Date
Jan 2021 — Dec 2024
Total Project Funding
$423,250
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant number: 2003035
Project Site
Related Resources
